Glycomimetics Inc. Stock
Price
Target price
€0.14
€0.14
-3.950%
-0.0058
-3.950%
€9.13
10.09.24 / Tradegate
WKN: A1W8HZ / Symbol: GLYC / Name: GlycoMimetics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Glycomimetics Inc. Stock
Heavy losses for Glycomimetics Inc. today as the stock fell by -€0.006 (-3.950%).
Currently there is a rather negative sentiment for Glycomimetics Inc. with 3 Buy predictions and 8 Sell predictions..
However, we have a potential of 6115.47% for Glycomimetics Inc. as the target price of 9 € is above the current price of 0.14 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Glycomimetics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Glycomimetics Inc. in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Glycomimetics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Glycomimetics Inc. | -3.950% | 2.695% | -8.816% | -89.384% | -93.593% | -92.000% | -96.533% |
| Evolus Inc | 11.940% | 13.636% | 23.967% | 72.414% | 65.746% | 123.881% | - |
| Ardelyx Inc. | 1.210% | 12.579% | 6.313% | 33.302% | -1.522% | 427.037% | 18.843% |
| Coherus Bioscien. | -1.880% | 4.096% | -16.974% | -74.559% | -61.546% | -91.276% | -94.079% |
Comments
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat
GlycoMimetics, Inc. (NASDAQ: GLYC) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for GLYC provided by MarketBeat